Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...

Noninvasive monitoring of low-grade prostate cancer with a urinary biomarker test could reduce the need for biopsies and serial imaging, according to a study ...

Tempus AI is expanding its clinical oncology offering with the launch of ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer. ・The tool combines digital pathology and genomic ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

A landmark review of nearly 800,000 men has found that PSA blood tests do reduce prostate cancer deaths — a shift from ...

Screening for prostate cancer using a blood test likely reduces the risk of dying from prostate cancer and may also reduce the risk of dying from any cause. Screening likely makes little to no ...

Genomic profiling can help personalize cancer care, but patients may not be offered these tests due to a burdensome ...

CANYON COUNTY — Prostate cancer is the second leading cause of cancer death in men, with about one in seven men being diagnosed with prostate cancer in their lifetime, according to the American Cancer ...

Adverts for at-home prostate cancer tests that claim to offer a diagnosis, including one that suggests patients can “skip the doctors” have been banned by watchdogs. The Advertising Standards ...

Prostate cancer screening should not be made routinely available for the vast majority of men in the UK, a committee advising the Government has said. In a draft recommendation, the UK National ...